Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma

Figure 5

Survival curves uncover the relationships between five core DE IRGs and glioma patients’ survival in the TCGA cohort: (a) VEGFA (, 95% CI: 3.16-5.15, ), (b) SOCS3 (, 95% CI: 3.35-5.43, ), (c) THBS1 (, 95% CI: 2.31-3.72, ), (d) SPP1 (, 95% CI: 2.98-4.85, ), and (e) TGFB2 (, 95% CI: 3.64-5.92, ). DE IRGs: differentially expressed immune-related genes; TCGA: The Cancer Genome Atlas; VEGFA: vascular endothelial growth factor A; SOCS3: suppressor of cytokine signaling 3; THBS1: thrombospondin 1; SPP1: secreted phosphoprotein 1; TGFB2: transforming growth factor beta 2.

(a)

(b)

(c)

(d)

(e)